XML 19 R6.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Total
Impact of Adoption
Common Stock
Additional Paid-in Capital
Treasury Stock
Accumulated Other Comprehensive Income (Loss)
Accumulated (Deficit)
Accumulated (Deficit)
Impact of Adoption
Beginning balance (in shares) at Dec. 31, 2018     57,331,622   0      
Beginning balance at Dec. 31, 2018 $ 428,340 $ (502) $ 573 $ 1,006,822 $ 0 $ 0 $ (579,055) $ (502)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Purchase of treasury stock (in shares)         (23,952,756)      
Purchase of treasury stock (437,962)       $ (437,962)      
Exercise of stock options (in shares)     (111,660)          
Exercise of stock options (1,880)   $ (1) (1,879)        
Net income 35,504           35,504  
Ending balance (in shares) at Dec. 31, 2019     57,443,282   (23,952,756)      
Ending balance at Dec. 31, 2019 27,260   $ 574 1,008,701 $ (437,962) 0 (544,053)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Purchase of treasury stock (in shares)         (2,682,042)      
Purchase of treasury stock (30,626)       $ (30,626)      
Exercise of stock options (in shares)     (2,147,140)   (112,469)      
Exercise of stock options (12,815)   $ (22) (14,075) $ 1,282      
Reclass of stock options from liability to equity classification 37,661     37,661        
Private placement 444     (813) $ 1,257      
Private placement (in shares)         68,857      
Net income 149,221           149,221  
Ending balance (in shares) at Dec. 31, 2020     59,590,422   (26,678,410)      
Ending balance at Dec. 31, 2020 196,775   $ 596 1,059,624 $ (468,613) 0 (394,832)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Exercise of stock options (in shares)     (669,836)   (7,132)      
Exercise of stock options (2,418)   $ (6) (2,678) $ 266      
Exercise of stock warrants (in shares)     570,595          
Exercise of stock warrants 13,898   $ 6 13,892        
Stock compensation expense 8,094     8,094        
Foreign currency translation adjustment (8,047)         (8,047)    
Net income 101,577           101,577  
Ending balance (in shares) at Dec. 31, 2021     60,830,853   (26,685,542)      
Ending balance at Dec. 31, 2021 $ 314,715   $ 608 $ 1,084,288 $ (468,879) $ (8,047) $ (293,255)